Clinical Trial of PM54 in Advanced Solid Tumors Patients. — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Clinical Trial of PM54 in Advanced Solid Tumors Patients. — Stella

Recruiting

Back to Advanced Solid Tumor trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(3 sites)

United States

South Texas Accelerated Research Therapeutics, San Antonio, Texas

Belgium

Institut Jules Bordet, Anderlecht

Spain

HM Universitario Sanchinarro, Madrid, M

Key details

Phase

Early testing

Sponsor

PharmaMar

Enrollment target

~125 participants

Started

April 2023

Primary completion

December 2026

Age range

18 Years and older

Last updated September 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov